A Pharmacokinetic and Pharmacodynamic Study of the Potential Drug Interaction between Tasosartan and Atenolol in Patients with Stage 1 and 2 Essential Hypertension-Reference-Cited by-同舟云学术

A Pharmacokinetic and Pharmacodynamic Study of the Potential Drug Interaction between Tasosartan and Atenolol in Patients with Stage 1 and 2 Essential Hypertension

Published:2000-03 Issue:3 Volume:40 Page:231-241
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Andrawis Nabil S.,Battle Michele M.,Klamerus Karen J.,Burghart Peter H.,Neefe Lynne,Weinryb Ira,Mayer Philip,Abernethy Darrell B.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. Long-acting and short-acting diuretics in mild essential hypertension;Wing;Clin Exp Hypertens [A],1982

2. Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross-over study;Neuvonen;Br J Clin Pharmacol.,1978

3. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: a dynamic assessment;Davies;Am J Cardiol.,1976

4. Initial treatment of the young hypertensive: thiazide diuretic or beta-adrenoreceptor-blocking agent in a single daily dose?;Gordon;Clin Sci Mol Med.,1976

5. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension;Schwartz;J Cardiovasc Pharmacol.,1985

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virtual screening for finding inhibitor against the main protease of SARS-Cov-2 from the FDA-approved drugs database;International Conference on Biomedical and Intelligent Systems (IC-BIS 2022);2022-12-06

2. Current Awareness;Pharmacoepidemiology and Drug Safety;2000-07